International breast cancer prevention study launches in the United States and Canada

es national and international trials of cancer therapy, including trials for new cancer drugs, cancer prevention and supportive care to improve quality of life for people with cancer. Since its inception, the NCIC CTG has enrolled more than 40,000 patients from Canada and around the world in over 300 clinical trials.

Pfizer, Inc. manufactures exemestane under the brand name Aromasin and is providing the drug for the trial.

Women looking for more information about the ExCel research study and participating study centers in their community can visit www.excelstudy.com or call toll-free:

  • In the U.S. 1-800-4-CANCER
  • In Canada 1 888 939-3333

    About Exemestane

    Exemestane (Aromasin) was approved in the United States late in 1999 for the treatment of advanced breast cancer in postmenopausal women whose tumors have stopped responding to tamoxifen. Exemestane is approved by the FDA and Health Canada and is marketed by Pfizer, Inc. as Aromasin. It is also approved for use in Europe, Japan, and South America. It is currently used for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

    Results of the Intergroup Exemestane Study, published in the New England Journal of Medicine, revealed that 32 percent fewer women had a recurrence in their breast cancer when they switched to exemestane after two to three years of tamoxifen compared to those who continued on tamoxifen for a total of five years, the current standard of care. Additionally, twice as many women receiving tamoxifen developed second (or new) breast cancers than those treated with exemestane.

    Unlike other aromatase inhibitors, exemestane is a steroidal aromatase inactivator, which means it selectively targets and irreversibly binds to the aromatase enzyme, which is required to produce estrogen. Without estrogen, breast can

  • Contact: Samantha Kaplan
    Edelman Public Relations

    Page: 1 2 3 4

    Related medicine news :

    1. National Academies advisory: May 2 Symposium on International Science Policy
    2. Awards & fellowships at the International & American Association for Dental Research General Session
    3. Lectures, keynoters, symposia highlight International Dental Research meeting
    4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
    5. International gathering of experts to share retinoblastoma breakthroughs
    6. International trial of two microbicides begins
    7. International gathering at UH examines top computer code
    8. International trial finds benefits of breast MRI in women at high risk
    9. International study provides culture-by-culture clues to family violence and abuse
    10. St. Jude scientist wins International Society of Experimental Hematology award
    11. International MRC trial finds a routine treatment for head injury may do more harm than good

    Post Your Comments:

    (Date:10/13/2018)... ... October 13, 2018 , ... The National Fitness Foundation, ... announced LaRhonda Burley as its new Vice President of Partnerships & Marketing. ... and strengthen the mission of the President's Council by generating private sector investments ...
    (Date:10/11/2018)... ... October 11, 2018 , ... Bizmatics ... of all sizes and specialties. PrognoCIS , their Health IT Software – ... patients. , Greater Houston Healthconnect (GHH), the region’s health information exchange (HIE), serves ...
    (Date:10/6/2018)... ... , ... Jose Rodriguez- Feliz M.D is a board–certified plastic ... known for their exclusivity, and luxurious lifestyle publication is privileged to present Dr. ... the Haute Living network. , Haute Beauty consists of a prominent collective ...
    (Date:10/5/2018)... , ... October 05, 2018 , ... ... that will greatly enhance Operative Neurosurgery’s Surgical Video section, which currently includes 2-D ... reality to Operative Neurosurgery. Under this partnership, a select number of surgical videos ...
    (Date:10/5/2018)... ... October 05, 2018 , ... ... medical broadcasting company delivering education to healthcare professionals through an all-digital platform, ... destination designed exclusively for rheumatologists. , "This is a unique and ...
    Breaking Medicine News(10 mins):
    (Date:10/3/2018)... ... ... The Point of Grace Academy resides in rural Kisumu along the shores of ... HIV/AIDS in all of Kenya. Also, while the school sits on the shores of ... toxic chemicals, and algae blooms have rendered the water unsafe. , Consequently, the ...
    (Date:10/2/2018)... (PRWEB) , ... October 02, 2018 , ... ... announce the opening of The Refinery Medspa & Wellness, dedicated to bringing out ... , Grounded in science, The Refinery offers results-driven skin care treatments and products, ...
    (Date:10/2/2018)... ... October 02, 2018 , ... The Honey Space for Moms is ... opportunity for women in the community to meet the Honey Space for Moms team ... , Honey Space provides support groups for moms regarding work and life balance, miscarriage, ...
    Breaking Medicine Technology:
    Cached News: